Intravenous Infusions is trading at GHS 0.75 (+7.14%); no reliable company-specific announcement dated August 27, 2026, was found explaining the move.
- The latest notable update, dated August 4, 2026, concerned a return to profitability and planned equity funding, but predates this movement.
- Broader U.S. markets were mixed, offering no sufficiently clear explanation for the Ghana-listed stock’s gain.